U.S. markets close in 7 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
106.61-0.54 (-0.50%)
As of 3:53PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close107.15
Open107.01
Bid106.52 x 800
Ask106.52 x 800
Day's Range105.93 - 107.58
52 Week Range79.11 - 121.53
Volume5,230,516
Avg. Volume7,038,573
Market Cap188.399B
Beta (5Y Monthly)0.79
PE Ratio (TTM)28.75
EPS (TTM)3.71
Earnings DateOct 28, 2021 - Nov 01, 2021
Forward Dividend & Yield5.20 (4.85%)
Ex-Dividend DateOct 14, 2021
1y Target Est125.96
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-24% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AbbVie Inc.
    Analyst Report: AbbVie Inc.AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    9 days agoMorningstar
View more